India's Ministry of Chemicals and Fertilizers announced on October 17, 2026, that it will cap trade margins at 30% and reduce prices on 137 anti-cancer medicines by up to 70%, taking effect November 9, 2026. The expanded price controls target treatments for breast, prostate, colon, ovarian, and cervical cancers, as well as immunotherapies covering over 20 cancer types, in an effort to improve healthcare affordability across India's $2.6 billion oncology market.
Story comments
Loading comments…